Литература

Поставить закладку

Галстян Г.М., Клясова Г.А., Катрыш С.А., Золотовская И.К., Галстян А.Г., Городецкий В.М. Этиология нозокомиальных пневмоний у онкогематологических больных в отделении реанимации и интенсивной терапии // Клин. микробиол. и антимикроб. терап. — 2011. — Т. 13. — № 3. — С. 231–240.
Галстян Г.М., Костина И.Э, Катрыш С.А, Клясова Г.А., Карпова Т.И., Тартаковский И.С. Клинические проявления легионеллезной пневмонии у гематологических больных // Тер. архив. — 2014. — № 3. — С. 46–53.
Гельфанд Б.Р., Белоцерковский Б.З., Милюкова И.А., Гельфанд Е.Б. Эпидемиология и нозологическая структура нозокомиальных инфекций в отделении реанимации и интенсивной терапии многопрофильного стационара // Инфекции в хирургии. — 2014. — Т. 4. — С. 24–36.
Голубев А.М., Мороз В.В., Лысенко Д.В. и др. ИВЛ-индуцированное острое повреждение легких (экспериментальное, морфологическое исследование) // Общая реаниматология. — 2006. — Т. 4. — С. 8–11.
Городецкий В.М., Галстян Г.М., Клясова Г.А. Острая дыхательная недостаточность у больных в гематологической клинике // В кн. Программное лечение заболеваний системы крови / Под ред. В.Г. Савченко. — М.: Практика, 2012. — С. 1011–1031.
Диагностика и лечение микозов в отделениях реанимации и интенсивной терапии: Российские рекомендации / Отв. ред. Н.Н. Климко. — 2-е изд., доп. и перераб. — М.: Фармтек, 2015. — 96 с.
Заболотских И.Б., Грицан А.И., Киров М.Ю., Лебединский К.М., Мазурок В.А., Трембач Н.В., Ярошецкий А.И. Периоперационное ведение больных с сопутствующей дыхательной недостаточностью // Клинические рекомендации ФАР. — 2015.
Заболотских И.Б., Лебединский К.М., Горобец Е.С., Грицан А.И., Мусаева Т.С., Проценко Д.Н., Шифман Е.М., Эпштейн С.Л. Периоперационное ведение больных с сопутствующим ожирением // Клинические рекомендации ФАР. — 2014.
Клясова Г.А., Паровичникова Е.Н., Галстян Г.М., Михайлова Е.А., Любимова Л.С., Менделеева Л.П., Звонков Е.Е., Савченко В.Г. Алгоритм лечения и профилактики кандидоза и аспергиллеза у взрослых больных лейкозами, лимфомами и депрессиями кроветворения // Гематология и трансфузиология. — 2007. — Т. 52. — № 4. — С. 3–8.
Кузовлев А.Н., Мороз В.В., Голубев А.М., Половников С.Г. Ингаляционный тобрамицин в лечении в ИВЛ-ассоциированной пневмонии // Клин. фармакология и фармакотерапия. — 2014. — Т. 23 (4). — С. 1–7.
Методические указания МУ 4.2.2039–05 «Техника сбора и транспортирования биоматериалов в микробиологические лаборатории».
Мишнев О.Д., Щеголев А.И. Патологическая анатомия ОРДС // В рук.: Острый респираторный дистресс-синдром / Под ред. Б.Р. Гельфанда, В.Л.Кассиля. — М.: Литтерра, 2007. — С. 48–67.
Национальные клинические рекомендации «Определение чувствительности микроорганизмов к антимикробным препаратам» 2015 г. (документ доступен на сайте Федеральной медицинской электронной библиотеки — http://feml.scsml.rssi.ru/feml).
Нозокомиальная пневмония у взрослых // Российские национальные рекомендации. — М.: Боргес, 2009. — 90 с.
О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2014 году: Государственный доклад. — М.: Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека, 2015. — 206 с.
Основы инфекционного контроля. Практическое руководство. — 2-е изд. — American International Health Alliance, Washington, DC, 2005.
Острый респираторный дистресс-синдром: Практическое руководство / Под ред. Б.Р. Гельфанда, В.Л. Кассиля. — М.: Литтерра, 2007. — 232 с.
Пермяков Н.К. Патология реанимации и интенсивной терапии. — М.: Медицина, 1985.
Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений // Флебология. — 2010. — Т. 4 (1). — С. 4–37.
Руднов В.А. Вентиляторассоциорованная пневмония: дискуссионные вопросы терминологии, диагностики и эмпирической терапии // Клин. микробиология и антимикробная химиотерапия. — 2001.— Т. 3. — № 3. — С. 198–208.
Руднов В.А. и др. Инфекции в ОРИТ России: результаты национального многоцентрового исследования // Клин. микробиол. и антимикроб. химиотер. — 2011. — Т. 13 (4). — С. 294–304.
Санитарно-эпидемиологические требования к организациям, осуществляющим медицинскую деятельность. СанПин 2.1.3.2630. — 2010.
Спирин А.В., Гринберг Л.М. Респираторный дистресс-синдром взрослых, ассоциированный с беременностью (по данным патологоанатомических исследований) // Урал. мед. журн. — 2007. — № 12. — С. 72–75.
Тарлыков И.И., Рубан Г.И. Эпидемиологическая безопасность больных при оказании медицинской помощи // Эпидемиология и вакцинопрофилактика. — 2013. — Т. 6 (73). — Приложение 1. — С. 3–7. — Материалы III Конгресса по ВБИ 2013.
Тартаковский И.С., Груздева О.А., Галстян Г.М., Карпова Т.И. Профилактика, диагностика и лечение легионеллеза. — М.: Студия МДВ, 2013. — 344 с.
Тимофеев И.В. Патология лечения. — СПб.: Северо-Запад, 1999.
Федеральный закон от 30.03.1999 г. № 52-ФЗ «О санитарно-эпидемиологическом благополучии населения».
Фокин А.А., Галкин Д.В., Мищенко В.М. и др. Уроки эпидемиологических исследований нозокомиальных инфекций в России // Клин. микробиол. и антимикроб. химиотер. — 2008. — Т. 10. — № 1. — С. 4–14.
Формулировка патологоанатомического диагноза при болезнях органов дыхания (класс Х «Болезни органов дыхания» МКБ10). Клинические рекомендации / Составители Г.А. Франк, А.Г. Чучалин, А.Л. Черняев, О.Д. Мишнев и др. — М.: 2015. — 28 с.
Хмельницкий О.К., Хмельницкая Н.М. Оппортунистические глубокие микозы // В кн.: Патоморфология микозов человека. — СПб.: 2009. — С. 152–355.
Храпов К.Н. Респираторная поддержка при тяжелой пневмонии: Дисс. д-ра мед. наук. — СПб., 2011.
Чучалин А.Г., Синопальников А.И., Козлов Р.С., Тюрин И.Е., Рачина С.А. Внебольничная пневмония у взрослых: практические рекомендации по диагностике, лечению и профилактике: Пособие для врачей // Клин. микробиол. и антимикроб. химиотер. — 2010. — Т. 12 (3). — С. 186–225.
Эпидемиологическое наблюдение за инфекциями, связанными с оказанием медицинской помощи: Федеральные клинические рекомендации. — М., 2014. — 58 с.
Эпиднадзор за ИСМП в РФ. Роспотребнадзор. — М., 2013.
Ярошецкий А.И., Проценко Д.Н., Ларин Е.С., Гельфанд Б.Р. Роль оценки статической петли «давление-объем» в дифференциальной диагностике и оптимизации параметров респираторной поддержки при паренхиматозной дыхательной недостаточности // Анест. и реаним. — 2014. — № 2. — С. 21–26.
Ярошецкий А.И., Проценко Д.Н., Резепов Н.А., Гельфанд Б.Р. Настройка положительного давления конца выдоха при паренхиматозной ОДН: статическая петля «давление—объем» или транспульмональное давление? // Анест. и реаним. — 2014. — № 4. — С. 53–59.
Ярошецкий А.И., Проценко Д.Н., Игнатенко О.В., Ларин Е.С., Новоселова Е.В., Сулимова И.Ю., Гельфанд Б.Р. Роль оценки статической петли «давление-объем» и компьютерной томографии легких в дифференциальной диагностике паренхиматозной дыхательной недостаточности // Анест. и реаним. — 2013. — № 5. — С. 20–24.
A Guide to Infection Control in the Hospital. An official publication of the International Society for Infectious Diseases / Eds. G. Bearman, M. Stevens, M.B. Edmond, R.P. Wenzel. — 5nd ed. — Boston, MA, USA, 2014.
Aarts M.A., Hancock J.N., Heyland D. et al. Empiric antibiotic therapy for suspected ventilator-associated pneumonia: a systematic review and meta-analysis of randomized trials // Crit. Care Med. — 2008. — 36 (1). — P. 108–117.
Adair C.G., Gorman S.P., Feron B.M. et al. Implications of endotracheal tube biofilm for ventilator-associated pneumonia // Intensive Care Med. — 1999. — 25 (10). — P. 1072–1076.
Alhazzani W. et al. Small bowel feeding and risk of pneumonia in adult critically ill patients: a systematic review and meta-analysis of randomized trials // Crit. Care. — 2013. — 17. — R127.
Allan P.F., Osborn E.C., Chung K.K., Wanek S.M. High-frequency percussive ventilation revisited // J. Burn. Care. Res. — 2010. — 31. — P. 510–520.
Annual epidemiological report. European Centre for Disease Prevention and Control. — 2008.
Antonelli M. et al. A multiple-center survey on the use in clinical practice of noninvasive ventilation as a first-line intervention for acute respiratory distress syndrome // Crit. Care Med. — 2007. — 35 (1). — P. 18–25.
Arendrup M.C., Bille J., Dannaoui E., Ruhnke M., Heussel C.P., Kibbler C. ECIL-3 classical diagnostic procedures for the diagnosis of invasive fungal diseases in patients with leukaemia // Bone Marrow Transplant. — 2012. — 47 (8). — P. 1030–1045. — doi: 10.1038/ bmt.2011.246.
Ari F., Areabi H., Fink J.B. Evaluation of aerosol generator devices at 3 locations in humidified and non-humidified circuits during adult MV // Respir. Care. — 2010. — 55. — P. 837–844.
Aydemir H., Akduman D., Piskin N. et al. Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant acinetobacter baumannii ventilator-associated pneumonia // Epidemiol. Infect. — 2013. — 141 (6). — P. 1214–1222.
Bassetti M. et al. Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria // Intensive Care Med. — 2015. — 41. — P. 776–795.
Beal A.L. et al. Multiple organ failure syndrome in the 1990’s: SIRS and organ dysfunction // JAMA. — 1994. — 271. — P. 226–233.
Bekaert M. et al. Attributive mortality of ventilator associated pneumonia // Am. J. Respir. Crit. Care Med. — 2011. — 184. — P. 1133–1139.
Bloos F., Marshall J., Dellinger R., Vincent J.-L. et al. Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study // Crit. Care. — 2011. — 15. — R88.
Bonten M. VAP: preventing the inevitable // Clin. Infect. Dis. — 2011. — 52 (1). — P. 115–121.
Braggion C. et al. Short-term effects of three chest physiotherapy regimens in patients hospitalised for pulmonary exacerbations of cystic fibrosis: a cross-over randomized study // Pediatr. Pulmonol. — 1995. — 19. — P. 16–22.
Bregeon F. et al. Is ventilator-associated pneumonia an independent risk factor for death? // Anesthesiology. — 2001. — 94 (4). — P. 554–560.
Britigan B.E., Roeder T.L., Rasmussen G.T. et al. Interaction of the Pseudomonas aeruginosa secretory products pyocyanin and pyochelin generates hydroxyl radical and causes synergistic damage to endothelial cells. Implications for Pseudomonas-associated tissue injury // J. Clin. Invest. — 1992. — 90 (6). — P. 2187–2196.
Catherinot E. et al. Pneumocystis jirovecii pneumonia // Infect. Dis. Clin. North Am. — 2010. — 24. — P. 107–138.
Cavalcanti M., Ferrer M., Ferrer R. et al. Risk and prognostic factors of VAP in trauma patients // Crit. Care Med. — 2006. — 34 (4). — P. 1067–1072.
CDC Device-associated Module VAE. January 2015. Modified April, 2015.
Celis R. et al. Nosocomial pneumonia. A multivariate analysis of risk and prognosis // Chest. — 1988. — 93 (2). — P. 318–324.
Centers for Disease Control and Prevention: Ventilator-Associated Event (VAE). — 2014. — 10. — P. 1–46.
Chalmers J. et al. Epidemiology, antibiotic therapy, and clinical outcomes in healthcare-associated pneumonia // Clinical Infectious Diseases. — 2011. — 53 (2). — P. 107–113.
Chastre J. et al. Nosocomial pneumonia in patients with acute respiratory distress syndrome // AJRCCM. — 1998. — 157. — P. 1165–1172.
Chastre J., Fagon J. Ventilator-associated pneumonia // Am. J. Respir. Crit. Care Med. — 2002. — 165. — P. 867–903.
Chastre J., Wolff M., Fagon J.Y. et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial // JAMA. — 2003. —290 (19). — P. 2588–2598.
Chatburn R.L. Fundamentals of mechanical ventilation. — Cleveland Ohio: Mandu Press Ltd, 2003.
Chiurazzi C., Motos-Galera A., Torres A. Early identification of ventilator-associated pneumonia // Annual update in Intensive Care and Emergency Med. — 2015. — P. 3–14.
Chollet-Martin S. et al. Interaction between neutrophils and cytokines in blood and alveolar spaces during ARDS // Am. J. Respir. Crit. Care Med. — 1996. — 153. — P. 594–601.
Cilloniz C. et al. Hospital-acquired pneumonia in ICU // Int. J. Intensive Care. — 2013. — 20 (1). — P. 18–23.
Clinkscale D., Spihlman K., Watts P., Rosenbluth D., Kollef M.H. A randomized trial of conventional chest physical therapy versus high frequency chest wall compressions in intubated and non-intubated adults // Respir. Care. — 2012. — 57. — P. 221–228.
Conway Morris A., Anderson N., Brittan M. et al. Combined dysfunctions of immune cells predict nosocomial infection in critically illpatients // Br. J. Anaesth. — 2013. — 3.
Cook D.J., Kollef M.H. Risk factors for ICU-acquired pneumonia // JAMA. — 1998. — 279 (20). — P. 1605–1606.
Coppadoro A. et al. Novel preventive strategies for ventilator-associated pneumonia // Crit. Care. — 2012. —16. — 210.
Craven D., Hjialmarson K.I. Ventilator-associated tracheobronchitis and pneumonia: thinking outside the box // Clin. Infect. Dis. — 2010. — V. 51. — Suppl. 1. — P. 59–66.
Craven D.E., Kunches L.M., Kilinsky V. et al. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation // Am. Rev. Respir. Dis. — 1986. — 133 (5). — P. 792–796.
Cunha B.A., Brush J.L. Nosocomial and Healthcare-Associated Pneumonia. — Updated: Oct 01, 2015. — http://emedicine.medscape.com/article/234753-overview#a1.
Cunnion, K.M. et al. Risk factors for nosocomial pneumonia: comparing adult critical-care populations // Am. J. Respir. Crit. Care. Med. — 1996. — 153 (1). — P. 158–162.
Dallas J. et al. Ventilator-associated tracheobronchitis in a mixed surgical and medical ICU population // Chest. — 2011. — 139 (3). — P. 513–518.
de Larminat V., Montravers P, Dureuil B, Desmonts J.M. Alteration in swallowing reflex aft er extubation in intensive care unit patients // Crit. Care Med. — 1995. — 23 (3). — P. 486–490.
Declaux C. et al. Lower respiratory tract colonization and infection during severe ARDS // AJRCCM. — 1997. — 156. — P. 1092–1098.
Dos Santos C.C., Slutsky A.S. Mechanotransduction, ventilator-induced lung injury and multiple organ dysfunction syndrome // Intens Care Med. — 2000. — 26 (5). — P. 638–642.
Dudeck M.A., Weiner L.M., Allen-Bridson K. et. al. National Healthcare Safety Network (NHSN) Report, Data Summary for 2012, Device-associated Module // Am. J. Infect. Control. — 2013. — 41. — P. 1148–1166.
Dutkiiewick R., Hage A. Aspergillus infection in the critically ill // Pro Am. Thor. Soc. — 2010. — 7. — P. 204–209.
El Solh A., Okada M., Bhat A, Pietrantoni C. Swallowing disorders post orotracheal intubation in the elderly // Intensive Care Med. — 2003. — 29 (9). — P. 1451–1455.
El-Solh A.A., Hattemer A., Hauser A.R., Alhajhusain A., Vora H. Clinical outcomes of type III Pseudomonas aeruginosa bacteremia // Crit. Care Med. — 2012. — 40. — P. 1157–1163.
Escande B., Kuhn P., Rivera S. et al. Secondary surfactant deficiencies // Arch. Pediatr. — 2004. — 11 (11). — P. 1351–1359.
Fagon J.Y. et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques // Am. Rev. Respir. Dis. — 1989. — 139 (4). — P. 877–884.
Falcone M. et al. Healthcare-associated pneumonia // Int. J. Infectious. Diseases. — 2011. — 15. — P. 545–550.
Ferrari F., Liu Z.H., Lu Q. et al. Comparison of lung tissue concentrations of nebulized ceftazidime in ventilated piglets: ultrasonic versus vibrating plate nebulizers // Intensive Care Med. — 2008. — 34 (9). — P. 1718–1723.
Ferrari F., Lu Q., Girardi C., Petitjean O. et al. Nebulized ceftazidime in experimental pneumonia caused by partially resistant Pseudomonas aeruginosa // Intensive Care Med. — 2009. — 35 (10). — P. 1792–1800.
Franquet T. Imaging of pulmonary viral pneumonia // Radiology. — 2011. — 260 (1). — P. 18–39.
Frat J.-P. et al. High-flow oxygen through nasal cannula in acute hyperemic respiratory failure // N. Engl. J. Med. — 2015. — 372. — P. 2185–2196.
Garnacho-Montero J. et al. Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome // Crit. Care. — 2005. — 9. — R191–199.
Gattinoni L. et al. Lung recruitment in patients with ARDS // N. Engl. J. Med. — 2006. — 354. — P. 1775–1786.
Gattinoni L. et al. Prone positioning improves survival in severe ARDS: a pathophysiologic review and individual patient meta-analysis // Minerva Anestesiol. — 2010. — 76. — P. 448–546.
Gluecker T. et al. Clinical and radiologic features of pulmonary edema // RadioGraphics. — 1999. — 19. — P. 1507–1531.
Gristina G. et al. Noninvasive ventilation for acute respiratory failure in patients with hematologic malignancies: a 5-year multicenter observational survey // Cait. Care Med. — 2011. — 39 (10). — P. 2232– 2239.
Gruson D., Hilbert G., Vargas F. et al. Usefulness of computed tomography in early detection of pneumonia in leukopenic patients // Intensive Care Med. — 2001. — 27. — P. 444.
Guerin C. et al. Prone positioning in severe acute respiratory distress syndrome // N. Engl. J. Med. — 2013. — 368 (23). — P. 2159–2168.
Guidelines for management of adults with hospital-acquired, ventilator-associated and health-care associated pneumonia // Am. J. Respir. Crit. Care Med. — 2005. — 171 (4). — P. 388–416.
Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy. — 2008.
Hanberger H. et al. Infections, antibiotic treatment and mortality in patients admitted to ICUs in countries considered to have high levels of antibiotic resistance compared to those with low levels // BMC Infectious Diseases. — 2014. — 14. — P. 513–521.
Harbarth et al. Nosocomial infections in Swiss university hospitals: a multi-centre survey and review of the published experience // Swiss-Noso Network Schweiz Med Wochenschr. — 1999. — 129 (42). — P. 1521–1528.
Heyland D.K., Dodek P., Muscedere J. et al. Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia // Crit. Care. Med. — 2008. — 36 (3). — P. 737–744.
Holzapfel L., Chervet S., Madinier G. et al. Influence of long-term oroor nasotracheal intubation on nosocomial maxillary sinusitis and pneumonia: results of a prospective, randomized, clinical trial // Crit. Care Med. — 1993. — 21 (8). — P. 1132–1138.
Horan T.C., Andrus M., Dudeck M.A. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting // Am. J. Infect. Control. — 2008. — 36. — P. 309–332.
Hunter J. Ventilator associated pneumonia // BMJ. — 2012. — 344. — 3325.
Husain A.N. Pulmonary infection // In: Robbins and Cotran Pathologic Basis of Disease. — 9th ed. — Elsevier Inc, 2015. — P. 702–711.
Jones A.K., Fulcher N.B., Balzer G.J. et al. Activation of the Pseudomonas aeruginosa AlgU regulon through mucA mutation inhibits Cyclic AMP/Vfr signaling // J. Bacteriol. — 2010. — 192 (21). — P. 5709–5717.
Kalanuria A., Mirski M., Ziai W. VAP in ICU. Annual update in Intensive Care and Emergency Med. — 2014. — P. 65–77.
Kang M. et al. Role of HRCT in detection and characterization of pulmonary abnormalities in patients with febrile neutropenia // Lung India. — 2013. — 30 (2). — P. 124–130.
Kanne J.P., Yandow D.R., Meyer C.A. Pneumocystis jiroveci pneumonia: high-resolution CT findings in patients with and without HIV infection // AJR. — 2012. — 198. — W555–W561.
Kempainen R.R., Milla C., Dunitz J. et al. Comparison of settings used for high-frequency chest-wall compression in cystic fibrosis // Respiratory Care. — 2010. — 55. — P. 695–699.
Kieninger A., Lipsett P. Hospital-acquired pneumonia: pathophysiology, diagnosis, and treatment // Surg. Clin. North Am. — 2009. — 89. — P. 439–461.
Klompas M., Kleinman K., Murphy M. Descriptive epidemiology and attributive morbidity of ventilator-associated events // Infect. Control. Hosp. Epidemiol. — 2014. —35 (5). — P. 502–510.
Klompas M. The paradox of ventilator-associated pneumonia prevention measures // Crit Care. — 2009. — 13. — http://dx.doi.org/10.1186/cc8036.
Klompas M. et al. Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals: 2014 Update // Infection Control and Hospital Epidemiol. — 2014. — 35 (8). — P. 915–936.
Koff M.D., Corwin H.L., Beach M.L., Surgenor S.D., Loftus R.W. Reduction in ventilator associated pneumonia in a mixed intensive care unit after initiation of a novel hand hygiene program // J. Crit. Care. — 2011. — 26 (5). — P. 489–495.
Kollef M. et al. Economic impact of ventilator-associated pneumonia in large matched cohort // Infect. Control. Hosp. Epidemiol. — 2012. — 33. — P. 250–256.
Kuhn Ch., Craighead J.E. et al. Infections of the lung // In: Anderson’s Pathology. — 10th ed. — St. Louis: Mosby Inc, 1996. — P. 1488–1498.
Kutz A., Briel M., Christ-Crain M. et al. Prognostic value of procalcitonin in respiratory tract infections across clinical settings // Crit Care. — 2015. — 19. — P. 74.
Kwon S.J., Jeon T., Seo D. et al. Quantitative PCR for etiologic diagnosis of methicillin-resistant staphylococcus aureus pneumonia in intensive care unit // Tuberc. Respir. Dis. (Seoul). — 2012. — 2 (3). — P. 293–301.
Labeau S.O., Van de Vyver K., Brusselaers N. et al. Prevention of ventilator-associated pneumonia with oral antiseptics: A systematic review and meta-analysis // Lancet Infect. Dis. — 2011. — 11 (11). — P. 845–854.
Lambert M.L. et al. Clinical outcomes of health-care associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study // Lancet Infect. Dis. — 2011. — 11. — P. 30–38.
Lambiase A., Piazza O., Rossano F. et al. Persistence of carbapenem-resistant acinetobacter baumannii strains in an Italian intensive care unit during a forty-six month study period // New Microbiol. — 2012. — 35 (2). — P. 199–206.
Lau G.W., Hassett D.J., Britigan B.E. Modulation of lung epithelial functions by Pseudomonas aeruginosa // Trends Microbiol. — 2005. — 13. — P. 389–397.
Le Gal G. et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva score // Ann. Inter. Med. — 2006. — 144 (3). — P. 165–171.
Leng Y.X., Song Y.H. et al. Effect of 45 degree angle semirecumbent position on ventilator-associated pneumonia in mechanical ventilated patients: A meta-analisis // Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. — 2012. — 24 (10). — P. 587–591.
Liam C.K., Pang Y.K., Poosparajah S. Pulmonary tuberculosis presenting as community-acquired pneumonia // Respirology. — 2006. — 11. — P. 786–792.
Lichtenstein D. General Ultrasound in the Critically Ill. — New York, NY: Springer, 2004;
Lichtenstein D.A., Mezière G., Lascols N., Biderman P., Courret J.P., Gepner A., Goldstein I., Tenoudji-Cohen M. Ultrasound diagnosis of occult pneumothorax // Crit. Care Med. — 2005. — 33 (6). — P. 1231–1280
Lin Q., Fu F., Shen L., Zhu B. Pentraxin 3 in the assessment of ventilatorassociated pneumonia: an early marker of severity // Heart Lung. — 2013. — 42 (2). — P. 139–145.
Linda R. Greene et al. Guide to the Elimination of Ventilator-Associated Pneumonia, 2009. — APIC, 2009.
Lu Q., Girardi C., Zhang M. et al. Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa // Intensive Care Med. — 2010. — 36 (7). — P. 1147–1155.
Lu Y.T., Han C.L., Wu C.L. et al. Proteomic profiles of bronchoalveolar lavage fluid from patients with ventilator-associated pneumonia by gel-assisted digestion and 2-D-LC/MS/MS // Proteomics Clin. Appl. — 2008. — 2 (9). — P. 1208–1222.
Lukaszewicz A.C., Grienay M., Resche-Rigon M. et al. Monocytic HLADR expression in intensive care patients: interest for prognosis and secondary infection prediction // Crit. Care Med. — 2009. — 37. — P. 2746–2752.
Luyt C.E., Clavel M., Guntupalli K. et al. Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia // Crit. Care. — 2009. — 13 (6). — R200.
Macht M., Wimbish T., Bodine C., Moss M. ICU-acquired swallowing disorders // Crit. Care Med. — 2013. — 41 (10). — P. 2396–2405.
Magill S.S. Multistate Point-Prevalence Survey of Health Care-Associated Infections // The New England Journal of Medicine. — 2014. — 370 (13). — P. 1198–1208.
Magret M., Lisboa T., Martin-Loeches I. et al. Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: a prospective and observational multicenter study // Crit. Care. — 2011. — 15. — R62. — 26.
Martin T.R. et al. The function of lung and blood neutrophils in patients with the ARDS: implications for the pathogenesis of lung infections // Am. Rev. Respir. Dis. — 1991. — 144. — P. 254–262.
Martinez J.A., Cobos-Trigueros N., Soriano A. et al. Influence of Empiric Therapy with a beta-Lactam Alone or Combined with an Aminoglycoside on Prognosis of Bacteremia Due to Gram-Negative Microorganisms // Antimicrob. Agents Chemother. — 2010. — 54 (9). — P. 3590–3596.
Martin-Loeches I., Papiol E., Almansa R. et al. Intubated patients developing tracheobronchitis or pneumonia have distinctive complement system gene expression signatures in the pre-infection period: a pilot study // Med. Intens. — 2012. — 36 (4). — P. 257–263.
Maruyama T. et al. A new strategy for health-associated pneumonia // Clinical Infectious Diseases. — 2013. — 57 (10). — P. 1373–1383.
Masterton R. et al. Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy // J. of Antimicrobial Chemotherapy. — 2008. — 62 (1). — P. 5–34.
Matsubara O., Takumara T., Nasu M. et al. Pathological changes of the lungs after prolonged inhalation of high concentrations of oxygen // Virchows Arch. A. Pathol. Anat. Histopathol. — 1986. — 408 (5). — P. 461–474.
Mayo P.H., Doelken P. Pleural Ultrasonography // Clin. Chest. Med. — 2006. — 27 (2). — P. 215–227.
Meduri G.U. et al. Pneumonia in ARDS. A prospective evaluation of bilateral bronchoscopic sampling // AJRCCM. — 1998. — 158. — P. 870–850.
Meersseman W. et al. Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study // Intensive Care Med. — 2009. — 35. — P. 1526–1531.
Mercier E. et al. Aerosol delivery of amikacin by three nebulizers of varying efficiency in patients on mechanical ventilation // Am. J. Respir. Crit. Care Med. — 2004. — 7. — A657.
Merrell D.S., Falkow S. Frontal and stealth attack strategies in microbial pathogenesis // Nature. — 2004. — 430. — P. 250–256.
Montravers P., Veber B., Aubover C. et al. Diagnostic and therapeutic management of nosocomial pneumonia in surgical patients: results of EOLE study // Crit. Care Med. — 2002. — 30 (20). — P. 368–375.
Morrill H.J., Pogue J.M., Kaye K.S., LaPlante K.L. Treatment options for carbapenem-resistant Enterobacteriaceae infections. — Open Forum Infect. Dis., 2014.
Morris A., Kefala K., Wilkinson T. et al. Diagnostic importance of pulmonary interleukin-1beta and interleukin-8 in ventilator-associated pneumonia // Thorax. — 2010. — 65 (3). — P. 201–207.
Morris A.C. et al. Reducing ventilator-associated pneumonia in intensive care: Impact of implementing a care bundle // Crit. Care Med. — 2011.
Mortensen B.L., Skaar E.P. Host-microbe interactions that shape the pathogenesis of acinetobacter baumannii infection // Cell. Microbiol. — 2012. — 14 (9). — P. 1336–1344.
Muscedere J. et al. Subglottic secretion drainage for prevention of ventilator-associated pneumonia: a systematic review and meta-analysis // Crit. Care Med. — 2011. — 39 (8). — P. 1985–1991.
Nair G.B., Niederman M.S. Ventilator-associated pneumonia: present understanding and ongoing debates // Int. Care Med. — 2015. — 41. — P. 34–48.
Neumann S., Krause S.W., Maschmeyer G., Schiel X., von Lilienfeld-Toal M. Infectious Diseases Working Party (AGIHO); German Society of Hematology and Oncology (DGHO). Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors : guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO) // Ann. Hematol. — 2013. — 92 (4). — P. 433–442. — doi: 10.1007/s00277-013-1698-0.
Nguyen E.V., Gharib S.A., Palazzo S.J. et al. Proteomic profiling of bronchoalveolar lavage fluid in critically ill patients with ventilator-associated pneumonia // PLoS One. — 2013. — 8 (3). — e58782. — doi: 10.1371/journal.pone.0058782.
Niederman M. Hospital-acquired pneumonia, health care-associated pneumonia, ventilator-associated pneumonia, and ventilator-associated tracheobronchitis: definitions and challenges in trial design // Clinical Infectious Diseases. — 2010. — 51 (S1). — P. 12–17.
Niederman M.N., Chastre J., Corkery K. et al. BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia // Intensive Care Med. — 2012. — 38. — P. 263–271.
Nordmann P., Dortet I., Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm! // Trends Mol. Med. — 2012. — 18. — P. 263–272.
Nseir S., Di Pompeo C., Soubrier S. et al. Impact of ventilator-associated pneumonia on outcome in patients with COPD // Chest. — 2005. — 128. — P. 1650–1656.
Pai M., Zwerling A., Menzies D. Sysematic review: a cell-based assays for the diagnosis of latent tuberculosis infection: an update // Ann. Inter. Med. — 2008. — 149. — P. 177–184.
Palazzo S.J., Simpson T.A., Simmons J.M., Schnapp L.M. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as a diagnostic marker of ventilator-associated pneumonia // Respir. Care. — 2012. — 57 (12). — P. 2052–2058.
Palomar M. et al. Impact of hospital size in the nosocomial infection rate in ICU // Int. Care Med. — 2008. — 34 (Suppl. 1).
Pappas P.G. et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Disease Society of America // Clin. Infect. Dis. — 2009. — 48. — P. 503–535.
Paul M., Benuri-Silbiger I., Soares-Weiser K. et al. Beta-Lactam monotherapy versus beta-lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials // BMJ. — 2004. — 328. — P. 668–672.
Pelekanou A., Tsagkaris I., Kotsaki A. et al. Decrease of CD4 lymphocytes and apoptosis of CD14 monocytes are characteristic alterations in sepsis caused by ventilator-associated pneumonia: results from an observational study // Crit. Care. — 2009. — 13. — R172.
Pelosi P., Rocco P.R., de Abreu G.M. Use of computer tomography scanning to guide lung recruitment and adjust positive-end expiratory pressure // Crit. Opin. Crit. Care. — 2011. — 17 (3). — P. 268–274.
Pelosi P., Barassi A., Severgnini P., Gomiero B. et al. Prognostic role of clinical and laboratory criteria to identify early ventilator-associated pneumonia in brain injury // Chest. — 2008. — 134 (1). — P. 101–108.
Petrikkos G. et al. Epidemiology and clinical manifestations of mucormycosis // Clin. Infect. Dis. — 2012. — 54 (Suppl. 1). — S23–34.
Piazza O., Wang X. A clinical approach to ventilator associated pneumonia // Clin. Transl. Med. — 2014. — 3. — P. 26.
Pneumonia in adults: diagnosis and management. NICE guidelines [CG191]. Published date: December 2014.
Pugh R., Grant C., Cooke R.P. et al. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults // Cochrane Database Syst. Rev. — 2011. — issue 10. — CD007577.
Pugin J., Auckenthaler R., Mili N. et al. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic blind broncho-alveolar lavage fluid // Am. Rev. Respir. Dis. — 1991. — 143. — P. 1121–1129.
Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee // MMWR Recomm. Rep. — 2004. — 53(RR–3). — P. 1–36.
Rello J. et al. Epidemiology and outcomes of ventilator–associated pneumonia in large US database // Chest. — 2002. — 122. — P. 2115– 2121.
Risk factors and prevention of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults. — http://www.uptodate.com/contents/risk-factors-and-prevention-of-hospital-acquired-ventilator-associated-and-healthcare-associatedpneumonia-in-adults.
Rodriguez A., Povoa P., Nseir S. et al. Incidence and diagnosis of ventilator-associated tracheobronchitis in intensive care unit: an international online survey // Crit. Care. — 2014. — 18 (1). — R32.
Rodriguez-Bano J., Cisneros J.M., Cohos-Trigueros N. et al. Diagnosis and antimicrobial treatment on invasive infections due to multidrugresistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology // Enferm Infecc. Microbiol. Clin. — 2015. — 33 (5). — 337.
Rodriguez-Creixems M., Munoz P. et al. Diagnosis of nosocomial pneumonia // Antibiotics for Clinicians. — 1997. — 1. — Suppl. 2. — P. 29–34.
Rogers A.J., McGeachie M., Baron R.M. et al. Metabolomic derangements are associated with mortality in critically ill adult patients // PLoS One. — 2014. — 9 (1). — e87538.
Rouby J.J. Histology and microbiology of ventilator-associated pneumonias // Semin. Respir. Infect. — 1996. — 11 (1). — P. 54–61.
Santini F., Onorati F., Telesca M. et al. Selective pulmonary pulsatile perfusion with oxygenated blood during cardiopulmonary bypass attenuates lung tissue inflammation but does not affect circulating cytokine levels (dagger) // Eur. J. Cardiothoracic. Surg. — 2012. — 42. — P. 942–950.
Sarah S. Lewis et al. Epidemiology of Methicillin-Resistant Staphylococcus aureus Pneumonia in Community Hospitals Infect Control Hosp Epidemiol. — 2014. — 35 (12). — P. 1452–1457.
Sawa T., Shimizu M., Moriyama K., Wiener-Kronish J. Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review // Crit. Care. — 2014. — 18. — 668.
Schleicher G.K. et al. Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia // Eur. Respir. J. — 2005. — 25. — P. 688–692.
Seidenfeld J.J. et al. Incidence, site and outcome of infections in patients with the ARDS // Am. Rev. Respir. Dis. — 1986. — 134. — P. 12–16.
Shan J., Chen H.L., Zhu J.H. Diagnostic Accuracy of Clinical Pulmonary Infection Score for Ventilator-Associated Pneumonia: A Meta-analysis // Respir. Care. — 2011. — 56 (8). — P. 1087–1094.
Sheard S., Rao P., Devaraj A. Imaging of acute respiratory distress syndrome // Respir. Care. — 2012. — 57 (4). — P. 607–612.
Silvestri L. et al. Effectiveness of oral Chlorhexidine on nosocomial pneumonia, causative micro-organisms and mortality in critically ill patients: a systematic review and meta-analysis // Minerva Anestesiol. — 2014. — 80. — P. 805–820.
Smith L.A., Kauffman C.A. Pulmonary fungal infections // Respirology. — 2012. — 17. — P. 913–926.
Smith R.S., Wolfgang M.C. and Lory S. An adenylate cyclase-controlled signaling network regulates Pseudomonas aeruginosa virulence in a mouse model of acute pneumonia // Infect. Immun. — 2004. — 72. — P. 1677–1684.
Sopena N., Sabrià M. and the Neunos 2000 Study Group. Multicenter Study of Hospital-Acquired Pneumonia in Non-ICU Patients // Chest. — 2005. — 127. — P. 213–219.
Squadrone V. et al. Early CPAP prevents evolution of acute lung injury in patients with hematologic malignancy // Intensive Care Med. — 2010. — 36 (10). — P. 1666–1674.
Steingart K.R. et al. Commercial serologic antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review // PLoS Mes. — 2007. — 4:e202.
Su L.X., Meng K., Zhang X. et al. Diagnosing ventilator-associated pneumonia in critically ill patients with sepsis // Am. J. Crit. Care. — 2012. — 21 (6). — e110–e119.
Sutherland K.R. et al. Pulmonary infection during the ARDS // Am. J. Respir. Crit. Care Med. — 1995. — 152. — P. 550–556.
Sydnor E., Perl T. Hospital epidemiology and infection control in acute-care settings // Clin. Microbiology Reviews. — 2011. — 24 (1). — P. 141–173.
Taccone F.S., Van den Abeele A.M., Bulpa P., Misset B., Meersseman W., Cardoso T., Paiva J.A., Blasco-Navalpotro M., De Laere E., Dimopoulos G., Rello J., Vogelaers D., Blot S.I. AspICU Study Investigators. Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes // Crit. Care. — 2015. — 19. — P. 722. — doi: 10.1186/s13054-014-0722-7.
Tarnow-Mordi W. et al. Hospital mortality in relation to staff workload: a 4-year study in an adult intensive-care unit // Lancet. — 2000. — 356 (9225). — P. 185–189.
Torres A., Ferrer M., Badia J. Treatment Guidelines and outcomes of hospital-acquired and ventilator-associated pneumonia // Clin. Infect. Diseases. — 2010. — 51. — P. 48–53.
Toussaint M., Guillet M.-C., Paternotte S., Soudon P., Haan J. Intrapulmonary effects of setting parameters in portable intrapulmonary percussive ventilation devices // Respir. Care. — 2012. — 57. — P. 735–742.
Troullet J.L., Chastre J., Vuagnat A. et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria // Am. J. Respir. Crit. Care. Med. — 1998. — 157 (2). — P. 531–539.
Van der Poll T., Opal S. Host-patogen interaction in sepsis // Lancet Infect. Dis. — 2008. — 8. — P. 32–43.
Vargas F. et al. Physiologic effects of high-flow nasal cannula oxygen in critical care subjects // Respir. Care. — 2015. — 60 (10). — P. 1369– 1376.
Vicca A. Nursing staff workload as a determinant of methicillin-resistant Staphylococcus aureus spread in an adult intensive therapy unit // J. Hosp. Infect. — 1999. — 43 (2). — P. 109–113.
Viera S. et al. A scanographic assessment of pulmonary morphology in acute lung injury: significance of the lower inflection point detected on the pressure-volume curve // Am. J. Respir. Crit. Care. Med. — 1999. — 159. — P. 1612–1623.
Vincent J.L. et al. International study of the prevalence and outcomes of infection in intensive care units // JAMA. — 2009. — 202 (21). — P. 2323–2329.
Volpicelli G., Elbarbary M., Blaivas M., Lichtenstein D.A., Mathis G., Kirkpatrick A.W., Melniker L. et al. International evidence-based recommendations for point-of-care lung ultrasound // Intensive Care Med. — 2012. — 38(4). — P. 577–591.
Wang L., Li X., Yang Z., Tang X., Yuan Q., Deng L., Sun X. Semi-recumbent position versus supine position for the prevention of ventilator-associated pneumonia in adults requiring mechanical ventilation // Cochrane Database of Systematic Reviews. — 2016. — 1 Art. — CD009946.
Webb S.A.R., Kahler C.M. Bench-to-bedside review: bacterial virulence and subversion and of host defence // Crit. Care. — 2008. — 12. — 234.
Wilson A., Gray D., Karakiozis J., Thomas J. Advanced endotracheal tube biofilm stage, not duration of intubation, is related to pneumonia // J. Trauma Acute Care Surg. — 2012. — 72. — P. 916–923.
Winn W.C. Jr, La Sala P.R., Leslie K.O. Bacterial Infection // In: Dail and Hammar’s Pulmonary Pathology. Vol 1: Nonneoplastic Lung Disease / Ed. J.F. Jr. Tomashefski. — 3rd ed. — Springer Science + Business Media, 2008. — P. 228–315.
Winterbauer R.H., Durning R.B., Barron E. et al. Aspirated nasogastric feeding solution detected by glucose strips // Ann. Intern. Med. — 1981. — 95 (1). — P. 67–68.
Wunderlink R.G. et al. The radiologic diagnosis of autopsy-proven ventilator-associated pneumonia // Chest. — 1992. — 101. — P. 458– 463.
Yokoe D. et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospital: 2014 updates // Infection Control&Hospital Epidemiology. — 2014. — 35. — P. 967–977.
Zielińska-Borkowska U., Skirecki T., Złotorowicz M., Czarnocka B. Procalcitonin in early onset ventilator-associated pneumonia // J. Hosp. Infect. — 2012. — 81 (2). — P. 92–97.
Zimlichman E. et al. Health care-associated infections. A meta-analysis of costs and financial impact on US Health Care System // JAMA Intern Med. — 2013. — 173 (22). — P. 2039–2046.

Для продолжения работы требуется Регистрация

Предыдущая страница

Следующая страница